Literature DB >> 11797849

Experimental evaluation of a cell module for hybrid liver support.

J C Gerlach1, M Botsch, D Kardassis, P Lemmens, M Schön, J Janke, G Puhl, J Unger, M Kraemer, B Busse, C Böhmer, R Belal, M Ingenlath, M Kosan, B Kosan, J Sültmann, A Patzold, S Tietze, R Rossaint, C Müller, E Mönch, I M Sauer, P Neuhaus.   

Abstract

Aim of the study was to evaluate a hybrid liver support system in a porcine model of acute liver failure, after hepatectomy. Pigs with a body weight of 70+/-18 kg underwent total hepatectomy and porto-cavo-caval shunting as well as ligation of the bile duct and the hepatic artery. Control animals were connected to the system (including capillary membrane plasma separation) containing a four compartment bioreactor with integral oxygenation and decentralized mass exchange but without liver cells. The treatment group received hybrid liver support with the same system including 370+/-42 g primary isolated porcine parenchymal liver cells in co-culture with hepatocyte nursing cells, tissue engineered to liver- like structures at high density. Treatment started after complete recovery from anesthesia and was performed continuously. A positive influence on peripheral vascular resistance and a reduced need of catecholamine dosage was observed in the treatment group. Hybrid liver support with a cell module upscaled for clinical application significantly prolonged survival time in animals after hepatectomy with the longest survival being 26 hours in the control group an 57 hours in the treatment group.

Entities:  

Mesh:

Year:  2001        PMID: 11797849

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  6 in total

1.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

2.  Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors.

Authors:  Satdarshan P S Monga; Mariah S Hout; Matt J Baun; Amanda Micsenyi; Peggy Muller; Lekha Tummalapalli; Aarati R Ranade; Jian-Hua Luo; Stephen C Strom; Jörg C Gerlach
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 3.  Acute liver failure: a critical appraisal of available animal models.

Authors:  Mireille Bélanger; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 4.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

5.  Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors.

Authors:  R Guthke; K Zeilinger; S Sickinger; W Schmidt-Heck; H Buentemeyer; K Iding; J Lehmann; M Pfaff; G Pless; J C Gerlach
Journal:  Bioprocess Biosyst Eng       Date:  2006-03-21       Impact factor: 3.210

6.  Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems.

Authors:  Christian Thiel; Karolin Thiel; Alexander Etspueler; Thomas Schenk; Matthias H Morgalla; Alfred Koenigsrainer; Martin Schenk
Journal:  Crit Care       Date:  2010-07-22       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.